Literature DB >> 6286885

Avermectin B1a modulation of gamma-aminobutyric acid receptors in rat brain membranes.

S S Pong, C C Wang.   

Abstract

Avermectin B1a stimulates high-affinity binding of [3H]-gamma-aminobutyric acid (GABA) to receptors in washed rat brain membranes. Scatchard analysis of the data indicates that the drug does not significantly alter the apparent dissociation constant of GABA binding, but increases the detectable number of binding sites from 3.2 to 5.1 pmol/mg protein, (+)-Bicuculline completely blocks control and avermectin B1a-stimulated GABA binding, whereas picrotoxin antagonizes specifically the avermectin B1a-stimulated GABA binding. The avermectin B1a-stimulated GABA binding is also chloride ion-dependent, whereas GABA binding in the control is not. These observations suggest that the mechanism of avermectin B1a stimulation of GABA binding may involve the chloride ion channel.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286885     DOI: 10.1111/j.1471-4159.1982.tb08639.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans.

Authors:  J A Dent; M W Davis; L Avery
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

Review 2.  GABAA receptor: Positive and negative allosteric modulators.

Authors:  Richard W Olsen
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

Review 3.  Understanding the GABAA receptor: a chemically gated ion channel.

Authors:  F A Stephenson
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

4.  Actions of dihydroavermectin B1a on insect muscle.

Authors:  I R Duce; R H Scott
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

5.  Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin.

Authors:  Timothy Lynagh; Joseph W Lynch
Journal:  Front Mol Neurosci       Date:  2012-05-07       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.